1. Home
  2. SBET vs NEO Comparison

SBET vs NEO Comparison

Compare SBET & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

HOLD

Current Price

$4.92

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$14.25

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBET
NEO
Founded
1995
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2025
2008

Fundamental Metrics

Financial Performance
Metric
SBET
NEO
Price
$4.92
$14.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
8
Target Price
$18.71
$13.38
AVG Volume (30 Days)
9.7M
3.2M
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,055,000.00
N/A
Revenue This Year
$105.19
$10.63
Revenue Next Year
$13.53
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
666.04
N/A
52 Week Low
$4.46
$4.72
52 Week High
$40.46
$14.23

Technical Indicators

Market Signals
Indicator
SBET
NEO
Relative Strength Index (RSI) 38.23 79.73
Support Level N/A $11.49
Resistance Level $8.20 N/A
Average True Range (ATR) 0.35 0.67
MACD -0.02 0.29
Stochastic Oscillator 28.22 94.24

Price Performance

Historical Comparison
SBET
NEO

About SBET SharpLink Gaming Ltd.

SharpLink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: